Biotechnology transfer at the National Institutes of Health.
Chen
P S
PS
Office of the Director, National Institutes of Health, Bethesda, Maryland 20892.
D000620:Aminoimidazole Carboxamide / Q000031:analogs & derivatives; D000970:Antineoplastic Agents; D001709:Biotechnology / Q000191:economics / Q000331:legislation & jurisprudence*; D004992:Ethics, Medical; D006801:Humans; D007221:Industry; D009316:National Institutes of Health (U.S.) / Q000458:organization & administration*; D017239:Paclitaxel; D011506:Proteins; D012106:Research / Q000191:economics / Q000331:legislation & jurisprudence; D012109:Research Support as Topic / Q000191:economics / Q000331:legislation & jurisprudence*; D018581:Technology Transfer; D019716:Tissue Inhibitor of Metalloproteinase-2; D014230:Triazoles; D014481:United States
D000970:Antineoplastic Agents; D011506:Proteins; D014230:Triazoles; D019716:Tissue Inhibitor of Metalloproteinase-2; D000620:Aminoimidazole Carboxamide; C062058:carboxyamido-triazole; D017239:Paclitaxel